Morning
10:00 – 10:30 |
Registration and morning coffee |
10:30 – 10:35 |
Welcome and Introduction Professor Neil Poulter, Imperial College London |
10:35 – 11:10 |
CVD Prevention in T2DM The Story so far (Before EMPA-REG) Professor Neil Poulter, Imperial College London |
11:10 – 12:00 |
The SGLT2 and GLP1 Trials Results of the macro vascular outcomes Professor Naveed Sattar, University of Glasgow |
12:00 – 12:30 |
The DDP4- I Trials What prospects for the class? Professor Clifford J. Bailey, Aston University |
12:30 – 13:00 |
Hypoglycaemia and CVD Professor Simon Heller, The University of Sheffield |
13:00 – 13:40 |
Lunch |
Afternoon
13:40 – 14:10 |
Renal outcomes and glucose lowering in recent trials Professor John Wilding, University of Liverpool |
14:10 – 14:40 |
Heart Failure and T2DM Professor John G F Cleland, Glasgow University and Imperial College, London |
14:40 – 15:10 |
Lipid-lowering for optimal CVD prevention Professor Kausik Ray, Imperial College London |
15:10 – 15:45 |
Breakout groups: Groups will address one of four questions A. Optimising secondary prevention of CV events by glucose-lowering in T2DM: The logistics (not the drugs) B. Optimal BP management in T2DM/CKD/post CV events Targets/Thresholds/Drugs C. When to refer to the following specialities:
D. Optimal drug sequencing for glucose lowering in T2DM |
15:45 – 16:50 |
Table feedback from group discussion |
16:50 – 17:00 |
Summary and meeting closure |
17.00 – 18:00 |
Refreshments |
Find out more
About the Meeting
We explored the latest techniques and developments in cardio-metabolic science.
Programme
The invited faculty delivered an innovative, comprehensive and educational programme.
Location
The Meeting took place at Imperial College's Translation and Innovation Hub.